Literature DB >> 6539305

Establishment of an etoposide-resistant human epithelial tumour cell line in vitro: characterization of patterns of cross-resistance and drug sensitivities.

B T Hill, A S Bellamy.   

Abstract

A human tumour cell line resistant to etoposide ( VP16 -213) has been produced by fractionated X-irradiation exposure in vitro. Characterization of this line, derived from an epithelioid carcinoma of the tongue, revealed no significant differences in terms of several cytological and kinetic parameters compared with the parent line. Patterns of cross-resistance and drug sensitivities were determined by colony formation in soft agar after 24 h drug exposures. Three patterns of response were observed with the VP16 -213-resistant cells showing: marked cross-resistance to vincristine and teniposide , collateral sensitivity to 5- fluorouracil , hydroxyurea and cis-platinum, and comparable responses to the parent line for adriamycin, bleomycin, dibromodulcitol and methotrexate. This is the first demonstration that specific drug resistance can be induced by prior exposure to X-irradiation in vitro. This cell line appears to show a unique lack of cross-resistance between adriamycin and vincristine or etoposide. Preliminary investigations into possible mechanisms of etoposide resistance demonstrated similar DNA sedimentation profiles after etoposide exposure in both tumour cell lines, implying no differential effects of this drug on DNA of resistant cells. These data raise the possibility that the expression and mechanism of resistance may differ, depending on the manner in which drug resistance is induced.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539305     DOI: 10.1002/ijc.2910330509

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Antitumor activity of the two epipodophyllotoxin derivatives VP-16 and VM-26 in preclinical systems: a comparison of in vitro and in vivo drug evaluation.

Authors:  P B Jensen; H Roed; T Skovsgaard; E Friche; L Vindeløv; H H Hansen; M Spang-Thomsen
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 2.  Drug resistance in brain tumors.

Authors:  L G Feun; N Savaraj; H J Landy
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung.

Authors:  H Roed; L L Vindelov; I J Christensen; M Spang-Thomsen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

4.  Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screening.

Authors:  B T Hill; R D Whelan; L K Hosking
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

Review 5.  Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.

Authors:  B T Hill
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  P-glycoprotein gene amplification and expression in multidrug-resistant murine P388 and B16 cell lines.

Authors:  G Capranico; P De Isabella; C Castelli; R Supino; G Parmiani; F Zunino
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

7.  Twenty-sixth annual general meeting of the British Association for Cancer Research (in conjunction with the European Organization for Research and Treatment for Cancer--Pharmacokinetics and Metabolism Group and the Drug Metabolism Group). March 24-27, 1985, Birmingham, U.K.

Authors: 
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

8.  Establishment and characterization of resistant cells to etoposide (VP16) from a mouse breast cancer cell line, FM3A.

Authors:  E Takagi; H Kawatsu; K Shimokata; Y Nishiyama; K Kojima; S Yoshida
Journal:  Jpn J Cancer Res       Date:  1988-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.